Frontiers in Immunology (Mar 2024)
Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
- Tetiana Yatsenko,
- Tetiana Yatsenko,
- Ricardo Rios,
- Tatiane Nogueira,
- Yousef Salama,
- Satoshi Takahashi,
- Yoko Tabe,
- Toshio Naito,
- Kazuhisa Takahashi,
- Kazuhisa Takahashi,
- Koichi Hattori,
- Koichi Hattori,
- Beate Heissig
Affiliations
- Tetiana Yatsenko
- Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University School of Medicine, Tokyo, Japan
- Tetiana Yatsenko
- Department of Enzymes Chemistry and Biochemistry, Palladin Institute of Biochemistry of the National Academy of Science of Ukraine, Kyiv, Ukraine
- Ricardo Rios
- Institute of Computing, Federal University of Bahia, Salvador, Bahia, Brazil
- Tatiane Nogueira
- Institute of Computing, Federal University of Bahia, Salvador, Bahia, Brazil
- Yousef Salama
- An-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
- Satoshi Takahashi
- Division of Clinical Precision Research Platform, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
- Yoko Tabe
- Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University School of Medicine, Tokyo, Japan
- Toshio Naito
- Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University School of Medicine, Tokyo, Japan
- Kazuhisa Takahashi
- Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University School of Medicine, Tokyo, Japan
- Kazuhisa Takahashi
- Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan
- Koichi Hattori
- Center for Genome and Regenerative Medicine, Juntendo University, Graduate School of Medicine, Tokyo, Japan
- Koichi Hattori
- Department of Hematology/Oncology, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
- Beate Heissig
- Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University School of Medicine, Tokyo, Japan
- DOI
- https://doi.org/10.3389/fimmu.2024.1390698
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords
- COVID-19
- plasminogen activator inhibitor-1
- urokinase-type plasminogen activator
- interleukin-6
- fibrinolysis
- thrombosis